| Description | G protein-coupled receptors (GPCRs) constitute a vast protein family that encompasses a wide range of functions, including various autocrine, paracrine and endocrine processes. They show considerable diversity at the sequence level, on the basis of which they can be separated into distinct groups [ ]. The term clan can be used to describe the GPCRs, as they embrace a group of families for which there are indications of evolutionary relationship, but between which there is no statistically significant similarity in sequence []. The currently known clan members include rhodopsin-like GPCRs (Class A, GPCRA), secretin-like GPCRs (Class B, GPCRB), metabotropic glutamate receptor family (Class C, GPCRC), fungal mating pheromone receptors (Class D, GPCRD), cAMP receptors (Class E, GPCRE) and frizzled/smoothened (Class F, GPCRF) [, , , , ]. GPCRs are major drug targets, and are consequently the subject of considerable research interest. It has been reported that the repertoire of GPCRs for endogenous ligands consists of approximately 400 receptors in humans and mice []. Most GPCRs are identified on the basis of their DNA sequences, rather than the ligand they bind, those that are unmatched to known natural ligands are designated by as orphan GPCRs, or unclassified GPCRs [].The secretin-like GPCRs include secretin [ ], calcitonin [], parathyroid hormone/parathyroid hormone-related peptides [] and vasoactive intestinal peptide [], all of which activate adenylyl cyclase and the phosphatidyl-inositol-calcium pathway. These receptors contain seven transmembrane regions, in a manner reminiscent of the rhodopsins and other receptors believed to interact with G-proteins (however there is no significant sequence identity between these families, the secretin-like receptors thus bear their own unique '7TM' signature). Their N-terminal is probably located on the extracellular side of the membrane and potentially glycosylated. This N-terminal region contains a long conserved region which allows the binding of large peptidic ligand such as glucagon, secretin, VIP and PACAP; this region contains five conserved cysteines residues which could be involved in disulphide bond. The C-terminal region of these receptor is probably cytoplasmic. Every receptor gene in this family is encoded on multiple exons, and several of these genes are alternatively spliced to yield functionally distinct products. The major physiological role of calcitonin is to inhibit bone resorption thereby leading to a reduction in plasma Ca 2+. Further, it enhances excretion of ions in the kidney, prevents absorption of ions in the intestine, and inhibits secretion in endocrine cells (e.g. pancreas and pituitary). In the CNS, calcitonin has been reported to be analgesic and to suppress feeding and gastric acid secretion. It is used to treat Paget's disease of the bone. Calcitonin receptors are found predominantly on osteoclasts or on immortal cell lines derived from these cells. It is found in lower amounts in the brain (e.g. in hypothalamus and pituitary tissues) and in peripheral tissues (e.g. testes, kidney, liver and lymphocytes). It has also been described in lung and breast cancer cell lines. The predominant signalling pathway is activation of adenylyl cyclase through guanine nucleotide-binding proteins (G proteins), but calcitonin has also been described to have both stimulatory and inhibitory actions on the phosphoinositide pathway. | Name | GPCR, family 2, calcitonin receptor |
| Short Name | GPCR_2_calcitonin_rcpt | Type | Family |
Powered by
Have you tried our InterMine mobile apps?
and interoperation is funded by 
